PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 2, 2026Journal of Orthopaedic Surgery and Research0 citationsOpen Access

ZM-306416 prevents ovariectomy-induced bone loss by promoting osteoblastogenesis and inhibiting osteoclastogenesis

View Full Paper
YLYicheng LiSSShuo ShiDYDejian Yang

Key Points

  • To investigate the effects of ZM-306416 on bone loss caused by ovariectomy and its mechanisms of action.
  • Utilized an ovariectomy animal model to simulate osteoporosis.
  • Administered ZM-306416 and monitored bone density changes.
  • Analyzed Wnt/β-catenin and NF-κB/MAPK pathways for signaling responses.
  • ZM-306416 significantly promoted osteoblastogenesis.
  • It effectively inhibited osteoclastogenesis, leading to preserved bone density.
  • Activation of the Wnt/β-catenin pathway and suppression of NF-κB/MAPK cascades were confirmed.

Abstract

Our study revealed that ZM has a dual anti-osteoporosis effect by promoting osteoblastogenesis and inhibiting osteoclastogenesis, which is mediated by activation of the Wnt/β-catenin signaling pathway and suppression of the NF-κB/MAPK cascades. These findings suggest that ZM could be a promising therapeutic agent for alleviating osteoporosis.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Li et al. (2026) studied this question.

synapsesocial.com/papers/6980fed9c1c9540dea8114fchttps://doi.org/10.1186/s13018-025-06654-7
Ask AI
Helpful
Bookmark
Share
View Full Paper